SEC 13F Intelligence

Highlander Partners, L.P. / BMY

Highlander Partners, L.P.’s Bristol-Myers Squibb Co Position

Does Highlander Partners, L.P. own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 60.0K shares worth $3M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q4 2023
Shares
60.0K
% of Portfolio
+2.46%
Quarters Held
9
position exited

Position History BMY

Reported value by quarter
Q4 ’21: $6MQ4 ’21Q1 ’22: $7MQ2 ’22: $5MQ2 ’22Q3 ’22: $4MQ4 ’22: $4MQ4 ’22Q1 ’23: $4MQ2 ’23: $4MQ2 ’23Q3 ’23: $3MQ4 ’23: $3MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202360.0K$3M+2.46%
Q3 202360.0K$3M+3.44%
Q2 202360.0K$4M+4.31%
Q1 202360.0K$4M+5.63%
Q4 202260.0K$4M+5.85%
Q3 202260.0K$4M+6.35%
Q2 202260.0K$5M+6.08%
Q1 2022100.0K$7M+9.16%
Q4 2021100.0K$6M+7.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highlander Partners, L.P.’s full portfolio or all institutional holders of BMY.